Respiratory health management company Aluna has inhaled $15.3 million in Series B capital, CEO Charvi Shetty tells Axios exclusively.
Why it matters: Although dozens of apps and devices exist to help people with lung conditions manage their illness, few offer what Aluna aims to: a fully integrated, combined service that lets people see how they respond to medications in real time.
